Injection Pen Market: Synopsis
The report published by Market Research Future (MRFR) projects that the global injection pen market is marked to exhibit notable expansion at a CAGR of 6.5% during the forecast period of 2018-2023.
Global Injection Pen Market: Industry Updates
In January 2019, Johnson & Johnson has announced that it has received FDA approval for its patient-controlled injector for Tremfya which is used for treating moderate to severe plaque psoriasis for adults.
In January 2019, BD has announced the launch of new Nano pen needle which is designed for accurate subcutaneous insulin injection pens. This needle is built with ergonomic pen needle technology.
Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/6146
Global Injection Pen Market: Key Players
The prime players profiled by MRFR that are operating in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (the U.S.), Sanofi (France), Merck (the U.S.), Ypsomed (Switzerland), AstraZeneca (the U.K.), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (the U.S.), Owen Mumford (the U.K.), Novartis (Switzerland), Pfizer (the U.S.), Haselmeier (Switzerland), Jiangsu Delfu medical device Co. Ltd (China), and Biocon Ltd (India).
The global injection pen market is segmented on the basis of type, product, therapy, distribution channel, and end-user.
On the basis of type, the market is classified into disposable injection pens and reusable injection pens.
The global injection pen market on the basis of product is segmented into insulin pens and pen needles.
On the basis of therapy, the market is segmented as diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, and others. Diabetes is further segmented into insulin and GLP-1.
On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics.
On the basis of end-user, the global injection pen market is segmented into home care and hospitals and clinics.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American injection pen market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.
The Europe injection pen market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe.
The Asia Pacific injection pen market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.
The Middle Eastern and African injection pen market is segmented into the Middle East and Africa.
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/injection-pen-market-6146
Global Injection Pen Market: Regional Analysis
Geographically, the global injection pen market has been segmented into four major regions such as Europe, The Americas, Asia Pacific (APAC), and the Middle East and Africa.
Global Injection Pen Market, by Region Market Share, 2018 (%)
The Americas command the dominant share of the global injection pen market owing to the rapid development of healthcare technology which is aiding in the development of innovative self-drug delivery systems, high demand for injection pens among the population as a result of growing prevalence of chronic diseases caused due to various factors such as changing lifestyle, unhealthy dietary habits, genetic disorders, environmental agents and others, and increased healthcare expenditure due to rise in disposable income of the population in this region.
The Europe region commands the second largest share of the global injection pen market owing to the increased investments in the pharmaceutical industry to carry out research activities for the development of advanced treatment solutions, high demand for innovative drug administration systems and presence of well-developed healthcare infrastructure in this region.
The Asia Pacific region is exhibiting fastest growth in the global injection pen market owing to the increasing availability of self-drug administration systems at affordable prices, rise in awareness regarding self-drug delivery injection pens and high prevalence of diabetes among the population of this region. Lack of awareness is restraining the growth of the injection pen market in the Middle East and Africa region
Avail Discount at https://www.marketresearchfuture.com/check-discount/6146
Injection pens are Market extensively used for self-drug delivery by the patients suffering from chronic diseases. High prevalence of chronic diseases and increasing demand for self-drug administration systems in the healthcare sector of various regions are majorly propelling the growth of the global injection pen market. Increasing availability of affordable medical devices is also fueling the growth of the global injection pen market.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar